Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conferenceseries Ltd: World’s leading Event Organizer

Conference Series Conferences gaining more Readers and Visitors

Conference Series Web Metrics at a Glance

  • 3000+ Global Events
  • 25 Million+ Visitors
  • 25000+ unique visitors per conference
  • 70000+ page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Venereal Diseases 2017

About Conference

ConferenceSeries Ltd invites all the participants from all over the world to attend ‘2nd International Congress on Venereal Diseases’ during November 13-14, 2017 in Las Vegas, Nevada, USA which includes prompt Keynote presentations, Oral talks, Poster presentations and Exhibitions.

In line with the of 2nd International Congress on Venereal Diseases, addressing the most recent advances across the spectrum of Genital research from basic sciences to public health, Conference Highlights of various Venereal Diseases, Advances in Venereal Diseases, Vaccines and Vaccination, Public Awareness.

ConferenceSeries Ltd Organizes 300+ Conferences Every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 500+ Open access journals which contains over 50,000 eminent personalities, reputed scientists as editorial board members. 

Featuring 2 days of Scientific workshop, Special sessions, Speaker & Poster session, Industrial Expo. 300+ attendees from all over the world. 

Why to attend???

As mentioned earlier, Venereal Disease research, involves people from various disciplines and people form such various fields do not always get a chance to meet and discuss the current developments in their respective areas. Venereal Diseases seek to bring all such people together and thereby provide them a platform with which to discuss and exchange ideas with one another. The Venereal disease conference is set to be graced by World-renowned speakers who will shed light on the most recent techniques, tactics, and the newest updates in Venereal Diseases

Target Audience

·         Virologists

·         Immunologists

·         Microbiologists

·         Epidemiologists

·         Doctors

·         Public health planners

·         Primary Care Practitioners (Family Practice, Internal Medicine, General Practice)

·         Physician Assistants

·         Nurse Practitioners

·         Laboratory Professionals and

·         Healthcare professionals interested in screening, treating and counseling patients regarding infectious diseases.

Scientific Sessions

ConferenceSeries Ltd invites all the participants from all over the world to attend ‘2nd International Congress on Venereal Diseases’ during November  13-14 in Las Vegas, Nevada, USA which includes prompt Keynote presentations, Oral talks, Poster presentations and Exhibitions. 

In line with the of 2nd  International Conference on Human Papillomavirus, addressing the most recent advances across the spectrum of Genital research from basic sciences to public health, Conference Highlights will Human Papillomavirus, HPV in Men, Cancer and HPV, Cervical Cancer, HIV – Human Immunodeficiency Virus, Genital Herpes, Syphilis, Hepatitis B, Chlamydia Infection, Gonorrhoea, Chancroid, Pelvic Inflammatory Disease, Other Genital Infections, Vaccines and Vaccination, Public Awareness

TRACK 1: Human Papillomavirus

Virology of Human Papillomavirus  is a double-stranded DNA, non-enveloped capsid virus. Their genome has three functional coding regions. Genome organization is similar for all papillomaviruses which has one strand transcribed. Epidemiology of HPV Infection causes warts, which are noncancerous skin growths known as cutaneous warts. Organization of life cycle can be divided into discrete phases. Initial infection requires access of infectious particles to cells in the basal layer, which for some HPV types is thought to require a break in the stratified epithelium. Toxicity and pathogenesis, Infection by specific HPV types has been linked to the development of cervical carcinoma. HPV infects epithelial cells that undergo terminal differentiation and so encode multiple mechanisms to override the normal regulation of differentiation to produce progeny virions.  The mechanism of HPV  is very complicated as it infects basal epithelial cells, which constitute the onlt cell layer in an epithelium that is actively dividing.

The estimated global HPV prevalence was found to be higher rates in sub-Saharan Africa (24%), Eastern Europe (21%) and Latin America (16%).

Related conferences on Human Papillomavirus

2nd International Conference on Mycology & MushroomsSeptember 25-26, 2017 Chicago, Illinois, USA ,International Conference and Expo on Medical Virology August 31-September 1, 2017 Philadelphia, USA,11th World Congress onVirology27,28-July-2017 Vancouver, Canada,5th World Congress on Virology December 07-09, 2015 Atlanta, USA;7th World Congress on Virology November 21-23, 2016 Baltimore, USA; 3rd International Conference on HIV/AIDS, STDs & STIs, Nov 30-Dec 02, 2015, Atlanta, USA;4th International Conference on HIV/AIDS, STDS and STIS October 03-05, 2016 Miami, USA; 2nd World Congress on Infectious Diseases August 25-27, 2016 Philadelphia, USA  European Congress of Virology, Hamburg, Germany; American Society for Virology- Annual Meeting, Blacksburg, US; Virology, Buenos Aires, Argentina; ASM Conference on Infection and Cancer, Washington, US; Clinical Virology Symposium, Dayton Beach, Florida. 

TRACK 2:HIV (Human Immunodeficiency Virus).

HIV gradually attacks the immune system after an infection, after which the immunity is weakened, the virus destroys T-helper cell and replicates. Although, there are various strains of HIV, the major 2 types of strains that infect majority of population are

  • HIV-1: the most common type found worldwide
  • HIV-2: this is found mainly in Western Africa, with some cases in India and Europe.

HIV infection leads to AIDS, after a person’s immune system is too fragile, to fight off many infections, and develops when the HIV infection is very advanced. This is the last stage of HIV infection where the body can no longer defend itself and may develop various diseases, infections and if left untreated, death.

HIV is primarily transmission through body fluids, viz., blood (via transfusion), semen, vaginal and rectal secretions (through sex), and breast milk (lactating mothers to babies).

Related conferences on HIV (Human Immunodeficiency Virus)

2nd International Conference on Infectious Diseases & Diagnostic Microbiology September 13-14, 2017 Dallas, USA9th Global Summit and Expo on Vaccines & Vaccination November 30-December 02, 2015 San Francisco, USA; 13th Asia Pacific Global Summit and Expo on Vaccines & Vaccination November 10-12, 2016 Melbourne, Australia ; 10th Euro Global Summit and Expo on Vaccines & Vaccination June 16-18, 2016 Rome, Italy ;7th Middle East - Global summit and Expo on Vaccines & Vaccination, September 28-29, 2015 Dubai, UAE; 8th Indo Global summit and Expo on Vaccines, Therapeutics & Healthcare (VTH-2015) November 02-04, 2015 HICC, Hyderabad, India ; New Approaches to Vaccines for Human And Veterinary Tropical Diseases, Cape Town, South Africa; Vaccines, Lisbon, Portugal; Vaccine World Summit India Hyderabad, India; Annual World Congress of Vaccine Dalian, China; Vaccine Summit London, UK. 

TRACK 3: Genital Herpes 

Genital herpes is one of the major sexually transmitted infections, caused by the herpes simplex virus and affects the skin or mucous membranes of the genitals.

There are 2 types of herpes simplex virus (HSV):

·  HSV-1 most often affects the mouth and lips and causes cold sores or fever blisters and can spread from the mouth to the genitals during oral sex.

·  HSV type 2 (HSV-2) most often cause genital herpes and spreads through skin contact or through fluids from the mouth or genitals.

One can be infected with herpes if skin, vagina, penis, or mouth comes into contact with these parts of the infected individual. Genital HSV-2 infections are most commonly seen in women than men.

General symptoms includes, Decreased appetite, Fever, malaise, Muscle aches, swollen and tender lymph nodes in the groin,  small, painful blisters  with clear or straw-coloured fluid in the labia, vagina, cervix, around the anus, and on the thighs or buttocks, Penis, scrotum, Tongue, mouth, eyes, gums, lips, fingers, and other parts of the body. 

Related conferences on Genital herpes

2nd International Conference on Infectious Diseases & Diagnostic Microbiology September 13-14, 2017 Dallas, 3rd International Conference on Flu and Emerging Infectious Diseases October 30-November 1, 2017 Las Vegas, USA,2nd World Congress on Infectious Diseases August 25-27, 2016 Philadelphia, USA; International Conference on Infectious Diseases & Diagnostic Microbiology, October3-5, 2016; International Conference on Oral, Mouth and Throat Cancer August 18-20, 2016 Portland, USA ;4th International Congress on Bacteriology and Infectious Diseases May 16-18, 2016 San Antonio, USA; 4th International Conference on HIV/AIDS, STDS and STIS October 03-05, 2016 Miami, USA;  Infectious Diseases Conference, Hyderabad, India;Annual Infectious Diseases Conference, Sacramento, California; Emerging Diseases and Surveillance Conference, Vienna, Austria; International Symposium on HIV & Emerging Infectious Diseases (ISHEID), Marseille, France;Annual Canadian Conference on HIV/AIDS Research (CAHR), Manitoba, Canada.

TRACK 4: Syphilis 

Syphilis is a sexually transmitted disease (STD) that has very serious complications when left untreated, and the symptoms are divided into 3 stages - primary, secondary, latent, and late syphilis. You can get syphilis by direct contact with syphilis sore during sex. Syphilis can also be spread from an infected mother to her unborn baby. Symptoms of syphilis can be confused by symptoms of other STDs, as it has many possible symptoms. The painless syphilis sore can be confused for an ingrown hair, zipper cut, or other seemingly harmless bump. The non-itchy body rash that develops during the second stage of syphilis can show up on the palms of your hands and soles of your feet, or sometimes all over your body. Syphilis can also affect the eye and can lead to permanent blindness. This is called ocular syphilis. You could also be infected with syphilis and have very mild symptoms or none at all.

Related conferences on syphilis

15th World Oncologists Annual Conference15-16 November, 2017 New York, USA,International Conference on Cervical Cancer September 22-23, 2016 Vienna, Austria ; 2nd International Conference on Prostate Cancer and Treatment May 05-07, 2016 Chicago, USA ;6th World Congress on Cancer Therapy December 01-03, 2016 Baltimore, USA;  International Conference on Oral, Mouth and Throat Cancer August 18-20, 2016 Portland, USA ;4th International Conference on HIV/AIDS, STDS and STIS October 03-05, 2016 Miami, USA;  Paediatric Oncology, Brussels, Belgium; Cancer Vaccines, Whistler, Canada; Changing Prospects for cancer, Manchester, UK; Asian Pacific Organisation for Cancer Prevention, Brisbane, Australia; Onco Update Europe, Budapest, Hungary.

TRACK 5: Hepatitis B

Hepatitis B is a viral infection that attacks the liver and can cause both acute and chronic disease. The virus is transmitted through contact with the blood or other body fluids of an infected person. Hepatitis B is most commonly spread from mother to child at birth or through horizontal transmission by exposure to infected blood and various body fluids, as well as through saliva, menstrual, vaginal, and seminal fluids. Sexual transmission occurs, particularly in unvaccinated men or in heterosexual persons with multiple sex partners. Infection in adulthood leads to chronic hepatitis in less than 5% of cases. In addition, infection can occur during medical, surgical, dental procedures, tattooing, or through the use of razors and similar objects that can be contaminated with infected blood.

Related conferences on Hepatitis B

World Congress on Preventive Oncology July 20-21, 2017 Chicago, USA International Conference on Cervical Cancer September 22-23, 2016 Vienna, Austria ; 2nd International Conference on Gynecology & Obstetrics November 16-18, 2015 San Antonio, USA; Experts Meeting on Gynecologic Oncology May 19-21, 2016 San Antonio, USA ; 2nd International Conference on Gynecology & Obstetrics October 17-19, 2015 Dubai, UAE; International Conference on Oral, Mouth and Throat Cancer August 18-20, 2016 Portland, USA ;  Cancer Vaccines Masterclass Training London, United Kingdom; European Society of Gynaecological Oncology, Nice, France; Gynaecological Study Day, South Kensington, London, UK; Gynecology Oncology Conference, Barcelona, Spain; Cancer Study & Therapy Conference, Baltimore, USA.

TRACK 6: Chlamydia Infections 

Chlamydia is the most common sexually transmitted infection (STI) caused by bacteria, contracted generally while having unprotected sex with someone whose STI status is uncertain. The treatment for chlamydia is single or multiple doses of oral antibiotics. Unprotected sex is the main route a chlamydia infection is spread. New-born babies can acquire chlamydia from their infected mother during birth. Most of the times, the symptoms go unnoticed. Some of the most common symptoms include burning sensation during urination, yellowish-green discharge from the penis or vagina, pain in the lower abdomen, pain in the testicles, painful sexual intercourse in women. 

Related conferences chlamydia infection 

TRACK 7: Gonorrhoea

Gonorrhoea is a STI caused by Neisseria gonorrhoea. And the bacteria are mainly found in the discharge of the penis and vaginal fluid. Gonorrhoea is easily passed between people through unprotected sex or by sharing vibrators or other sex toys that haven't been washed and covered with a new condom each time they're used. The bacteria infect the cervix, urethra, rectum, and is passed from a pregnant woman to her baby. Gonorrhoea isn't spread by hugging, kissing, sharing baths, sharing cutlery, swimming pools, and toilet seats or by sharing towels as the bacteria can’t survive for long outside the body.

Related Conferences of Gonorrhoea 

 

TRACK 8: Chancroid 

The bacterium Haemophilus  ducreyi , attacks a tissue and produces an open sore, referred to as a chancroid or ulcer near to the external reproductive organs. The ulcer could bleed or produce a contagious fluid that can spread bacteria during intercourse or may also spread from skin-to-skin contact with an infected person. It’s a type of venereal disease- which is transmitted through sexual contact.

Symptoms include- varied sizes of painful ulcers, having a soft centre with grey to yellowish colour and defined, or sharp, edges which bleed easily when touched or during sexual intercourse Swelling in the groin and swollen lymph nodes that can break through the skin and oozes pus

Related conferences on Chancroid 

International Conference and Expo on Medical Virology August 31-September 1, 2017 Philadelphia,USAInternational Conference on Cervical Cancer September 22-23, 2016 Vienna, Austria ; Experts Meeting on Gynecologic Oncology May 19-21, 2016 San Antonio, USA ;2nd International Conference on Gynecology & Obstetrics October 17-19, 2015 Dubai, UAE; 8th Indo Global summit and Expo on Vaccines, Therapeutics & Healthcare (VTH-2015) November 02-04, 2015 HICC, Hyderabad, India ; 13th Asia Pacific Global Summit and Expo on Vaccines & Vaccination November 10-12, 2016 Melbourne, Australia ;  Pregnancy vaccines Birmingham, UK; PDA/FDA Vaccines Conference Bethesda, Maryland; Cancer Vaccines Masterclass Training London, United Kingdom; European Society of Gynaecological Oncology, Nice, France; Gynaecological Study Day, South Kensington, London, UK.

TRACK 9: Pelvic Inflamatory Disease 

Untreated sexually transmitted diseases can cause pelvic inflammatory disease (PID), which is a serious reproduction organ condition, in women. According to statistics, 1 in 8 women with a history of PID experience difficulties getting pregnant. One is likely to get PID, if they have an STD and do not get treated, or have multiple sex partners, or use an intrauterine device (IUD) for birth control methods. One should get examined immediately when experiencing pain in lower abdomen, have fever, or an malodorous unusual discharge from vagina, painful or bleeding intercourse, burning sensation while urinating, bleeding or spotting between periods.

Related conference on pelvic inflamatory Disease 

5th World Congress on Control and Prevention of HIV/AIDS, STDs & STIsJune 19-20, 2017 London, UK ,2nd International Conference on Prostate Cancer and Treatment May 05-07, 2016 Chicago, USA ;4th International Conference on HIV/AIDS, STDS and STIS October 03-05, 2016 Miami, USA; 4th International conference on Clinical Microbiology & Microbial Genomics, Oct 05-07, Philadelphia, USA; International Conference on Cancer Immunology and Immunotherapy July 28-30, 2016 Melbourne, Australia; 2nd World Congress on Infectious Diseases August 25-27, 2016 Philadelphia, USA ; International Congress on Men’s Health, New Delhi, India; Annual EAU Congress, Munchen, Germany; Congress of the Asia Pacific Initiative on Reproduction, Jakarta, Indonesia;Congress of the North Rhine-Westphalian Society of Urology, Munster, Germany; Reproduction Health Summit, London, UK. 

TRACK 10: Other Genital Infections 

Molluscum contagiosum is a skin infection caused by Molluscum contagiosum virus and produces benign raised lesions, or bumps, on the upper layers of the skin and is spread through direct contact with the lesion of an infected person or by contact with a contaminated object, such as a towel or any other piece of clothing. 

Related conferences on Other Genital Infections 

Annual Meeting on Viral Outbreaks and Epidemiology October 16-18, 2017 Baltimore, USA,2nd World Congress on Infectious Diseases August 25-27, 2016 Philadelphia, USA ; International Conference on Infectious Diseases & Diagnostic Microbiology, October3-5, 2016; International Conference on Oral, Mouth and Throat Cancer August 18-20, 2016 Portland, USA ;International Conference on Cancer Immunology and Immunotherapy July 28-30, 2016 Melbourne, Australia;4th International conference on Clinical Microbiology & Microbial Genomics, Oct 05-07, Philadelphia, USA;  International Symposium on HIV & Emerging Infectious Diseases (ISHEID), Marseille, France; Annual Canadian Conference on HIV/AIDS Research (CAHR), Manitoba, Canada; Infectious Diseases Conference, Hyderabad, India; Individualized Medicine in Infectious Diseases: a Practical Approach, Tübingen, Germany; Management of Infections in Septic Shock Patients, Istanbul, Turkey; Infection Prevention and Control Conference, Tübingen, Germany.

TRACK 11: Vaccines and Vaccination: 

Vaccines contain a attenuated, killed or weakened pathogenic microbe, that causes the disease. A vaccine stimulates your immune system to produce antibodies, to develop immunity to that disease without getting infected. Although, both antibiotics and vaccines are used to fight germs, their mode of action is different- vaccines are used to prevent disease, while antibiotics are used to treat diseases. There are various types of vaccines, viz., Live, attenuated vaccines, inactivated vaccines, subunit vaccines, toxoid vaccines, conjugate vaccines, DNA vaccines and recombinant vector vaccines.

Related conference on HPV treatment

29th Global Vaccines & Vaccination Summit and Expo November 30-December 01, 2017 Dubai, UAE,7th Annual Congress on Clinical Microbiology September 25-26, 2017 Chicago, USA, 4th International conference on Clinical Microbiology & Microbial Genomics, Oct 05-07, Philadelphia, USA; 5th World Congress on Virology December 07-09, 2015 Atlanta, USA;International Conference on Cancer Immunology and Immunotherapy July 28-30, 2016 Melbourne, Australia; 2nd International Conference on Retroviruses & Novel Drugs June 30-July 01, 2016 Cape Town, South Africa ;7th World Congress on Virology November 21-23, 2016 Baltimore, USA;6th World Congress on Cancer Therapy December 01-03, 2016 Baltimore, USA;  Viruses, Basel, Switzerland; Clinical Virology Symposium, Dayton Beach, Florida; Society for Virology, Munster, Germany; European Congress of Virology, Hamburg, Germany; American Society for Virology- Annual Meeting, Blacksburg, US

TRACK 12: Public Awareness: 

There are numerous foundations that work on the betterment on the society and help those suffering from STDs and STIs and other genital infections’ mentally and emotionally. These foundations help in creating awareness among masses especially the youngsters in the age-group of 16-30 years of age. These foundations help in the regular testing, counselling and treatment of the patients, helping them accept their condition and face the social stigma associated with the infections and discrimination.

 

 

Related conferences on Medications for HPV

2nd International Conference on Retroviruses & Novel Drugs June 30-July 01, 2016 Cape Town, South Africa; International Conference on Cancer Immunology and Immunotherapy July 28-30, 2016 Melbourne, Australia;4th International conference on Clinical Microbiology & Microbial Genomics, Oct 05-07, Philadelphia, USA; 8th Indo Global summit and Expo on Vaccines, Therapeutics & Healthcare (VTH-2015) November 02-04, 2015 HICC, Hyderabad, India ;International Conference on Infectious Diseases & Diagnostic Microbiology, October3-5, 2016; Vaccine and ISV, Paris, France; Drug Discovery For Parasitic Diseases, Tahoe City, US; EUROGEN, Salzburg, Austria; Sexually Transmitted Diseases Research, Sydney, Australia; Current topics in Infectious Diseases; Grindelwald, Switzerland.

TRACK 13: Advances in HPV test

A prospective, randomized study was conducted to compare the effect of cryotheraphy and CO2 laser therapy in treatment of genital warts. Biomolecular diagnosis of HPV infection has gained an increasing consideration in the scientific and clinical community, mainly because of the very high sensitivity and very high NPV. HPV Screening With Triage by Novel BiomarkersNested PCR approach for detection and typing of epidermodysplasia verruciformis-associated human papillomavirus types in cutaneous cancers from renal transplant recipients. This nested PCR that enables the detection of all known EV HPV types at relatively low-copy-number levels. New screening strategies identifying epigenetic changes.

Related conferences on Advances in HPV

International Conference and Expo on Medical Virology August 31-September 1, 2017 Philadelphia,USA ,5th World Congress on Virology December 07-09, 2015 Atlanta, USA; Vaccine Summit London, UK;6th World Congress on Cancer Therapy December 01-03, 2016 Baltimore, USA; 13th Asia Pacific Global Summit and Expo on Vaccines & Vaccination November 10-12, 2016 Melbourne, Australia ; 8th Indo Global summit and Expo on Vaccines, Therapeutics & Healthcare (VTH-2015) November 02-04, 2015 HICC, Hyderabad, India ;International Conference on Infectious Diseases & Diagnostic Microbiology, October3-5, 2016;  Vaccines, Lisbon, Portugal; Annual World Congress of Vaccine Dalian, China; Pregnancy vaccines Birmingham, UK; PDA/FDA Vaccines Conference Bethesda, Maryland; Vaccine World CIS CEE  Moscow, Russian Federation.

Market analysis

Sexually Transmitted Diseases (STDs) are called venereal Diseases (VDs) or Sexually Transmitted Infections (STIs). A range of strategies have been utilized for the identification of STDs that disagree based on the kind of illness. The objective of this report is to produce AN in-depth understanding of diagnostic tests of STDs. Rising incidences of fatal STDs, corresponding high-economic burden and resultant implementation of Provider-Initiated guidance and Testing (PICT) and Client-Initiated content and Testing (CICT) drive the growth of STD testing market. Asia-Pacific market is growing at a major rate attributable to the causative factors such as massive cohort of the target population (aged 15–44 years) and consequently high testing volumes. Moreover, increasing antibiotic resistance that raises the prevalence and incidence rates and consequently the testing volumes in these regions propel the expansion of STDs testing market. Also, countries like Republic of India and China have high proportion or incidence of HIV infections. Sexually transmitted disease could be a common incidence as a co-infection with HIV, augmenting the growth of STDs testing market.

The Asia-Pacific market for diagnostic testing of STDs is segmental on the basis of type of STDs into chlamydia, gonorrhea, syphilis, Human immunodeficiency Virus (HIV), Herpes Simplex Virus (HSV), Human benign tumor Virus (HPV) and chancroid testing segments. Based on point of testing, market is segmental into laboratories and point-of-care (PoC). Currently, laboratories perform bulk of the tests and would continue to hold larger share of the market, both in terms of volume and revenue. PoCs will grow at a relentless rate during the forecast period. On the premise of testing devices, the market is chiefly segmental into laboratory devices and POC testing devices.

The Asia-Pacific STDs testing market is segmental into China, Japan, India, Australia and others. Emerging economies like Bharat, China, Singapore and Malaysia square measure the potential geographies for the market growth attributable to up health care standards. The prevalence and incidence rate for STDs are high in countries such as China and Asian nation attributable to high populations in these countries, driving the growth of STDs testing market. Key players in the STDs testing market square measure adopting strategies such as approval and acquisition, to make their presence in the market. The companies profiled in this market include Hologic Inc., Becton poet and Company, Cepheid INC., Affymetrix INC, Alere Inc., Abott Laboratories and few others.

KEYTAKEAWAYS

• Extensive coverage of the Asia-Pacific sexually transmitted diseases (STDs) testing market including drivers, restraints and opportunities that would help professionals to better understand market behavior

•    Analyzing the present market trends, projections concerning the market potential for the period of 2014–2020 in terms useful area unit discussed

•    A comprehensive analysis of equipment types, applications, end users and geography segments allows the identification of growth opportunities at intervals the Asia-Pacific STDs testing market

•    Market attractiveness analysis for the Asia-Pacific STDs testing market provides strategic assistance to decision makers

• associate degree analysis of strategies utilized by key leaders within the Asia-Pacific STDs testing market would prove to be informative for professionals in the corporate sector

•    Porter’s five forces framework examines the competitive structure of Asia-Pacific STDs testing market and would be helpful for strategic industry analysis

• Ease of doing business analysis would help in making strategic business decisions

KEY MARKET SEGMENTS

The Asia-Pacific sexually transmitted diseases (STDs) testing market is segmented into STDs’ type, location of testing, testing devices and geography segments.

MARKET BY SEXUALLY TRANSMITTED illness types

•          Chlamydia testing

•          Syphilis testing

•          Gonorrhea testing

•          Herpes Simplex virus testing

•          Human papilloma virus testing

•          Human immunodeficiency virus testing

•          Chancroid testing

MARKET BY LOCATION OF TESTING

·         Laboratory testing

·         Commercial/private labs

·         Public health labs

·         Point-of-Care (PoC) testing

MARKET BY TESTING DEVICES

§  Laboratory devices: instruments and systems

§  Thermal cyclers – PCR

§  Lateral flow readers - immunochromatographic assays

§  Flow cytometers

§  Differential lightweight scattering machines

§  Absorbance micro plate reader - catalyst joined Immunosorbent Assay (ELISA)

§  POC testing devices: varied diagnostic kits

§  Phone chips (microfluidics + ICT)

§  Portable/bench top/rapid diagnostic kits

MARKET BY Geographic’s

·         China

·         Japan

·         India

·         Australia

·         Others

Past Conference Report

HPV 2016

Past Reports  Proceedings  Gallery  

To Collaborate Scientific Professionals around the World

Conference Date (10 Plenary Forums 2 days 1 Event)
November 13-14, 2017

For Sponsors & Exhibitors

sponsors@conferenceseries.com

Speaker Opportunity

Supported By

Journal of AIDS & Clinical Research Virology & Antiviral Research Journal of Genital System & Disorders Journal of Infectious Diseases & Therapy: open Access

All accepted abstracts will be published in respective Conferenceseries International Journals.

Abstracts will be provided with Digital Object Identifier by


What People Say....

Thank you very much for giving me the opportunity of speaking about our research interest in your HPV meeting.

Speaker

Kwang Poo Chang ,Chicago Medical School, USA

The conference was very enlightening especially in the international experts who presented.

Speaker

Mary B. Prendergast, National University, USA